bexarotene has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casali, BT; Landreth, GE; Reed-Geaghan, EG | 1 |
| Dricot, L; Hanseeuw, B; Ivanoiu, A; Lhommel, R; Maloteaux, JM; Octavea, JN; Pierrot, N; Quenon, L; Sindic, C | 1 |
2 other study(ies) available for bexarotene and Cognition Disorders
| Article | Year |
|---|---|
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Bexarotene; Cells, Cultured; Cognition; Cognition Disorders; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid; Receptors, Cytoplasmic and Nuclear; Retinoid X Receptors | 2018 |
Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Amyloidogenic Proteins; Bexarotene; Biomarkers; Cognition Disorders; Humans; Male; Mental Recall; Neuropsychological Tests; Receptors, Retinoic Acid; tau Proteins; Tetrahydronaphthalenes | 2016 |